"...Type 2 diabetes and other diseases and our preclinical programs, said Steven B. Engle, Chairman and CEO of XOMA. About XOMA XOMA discovers, develops and manufactures novel antibody therapeutics for its own proprietary pipeline as well as through license and..." . . . .